XT
BPMC

XTX Topco’s Blueprint Medicines BPMC Stock Holding History

XTX Topco’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,311
Closed -$647K – 2399
2025
Q1 		$647K Sell
7,311
-3,835
-34% -$374K 0.03% 836
2024
Q4 		$972K Buy
11,146
+8,946
+407% +$819K 0.08% 319
2024
Q3 		$204K Sell
2,200
-3,304
-60% -$328K 0.01% 1438
2024
Q2 		$593K Buy
+5,504
New +$551K 0.05% 578
2023
Q4 		– Sell
-4,852
Closed -$244K – 1623
2023
Q3 		$244K Buy
+4,852
New +$259K 0.04% 880

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

XTX Topco's BPMC Position: Q2 2025 in Review

XTX Topco sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 7,311 shares — an estimated $647K sold.

XTX Topco first reported a position in BPMC in Q3 2023 and held it in 5 quarters. The position peaked at $972K in Q4 2024. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • XTX Topco reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
  • XTX Topco sold 7,311 Blueprint Medicines shares in Q2 2025, an estimated $647K.
  • XTX Topco first reported a position in Blueprint Medicines in Q3 2023 and held it in 5 quarters.
  • XTX Topco's Blueprint Medicines position peaked at $972K in Q4 2024.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.